Thermo Fisher Scientific Inc. (TMO) Balance Sheet
As of 2026-06-27 (10-Q), Thermo Fisher Scientific Inc. (TMO) reported total assets of $113.2B and shareholders' equity of $52.7B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $4.1B. Long-term debt: $42.3B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TMOThermo Fisher Scientific Inc.Follow TMO — free
—
Price chart with a free account
- Market cap
- 249.1B
- P/E TTM
- 36.2
- Dividend yield
- 0.3%
- 52-week
- —
- Next earnings
- 27 Jan, in 95 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.56 | 0.92 | 1.02 | 0.81 | 5.83 | 1.34 | 0.45 | 0.79 | 1.34 | 2.10 | 2.40 | 10.33 | 4.48 | 8.52 | 8.08 | 4.01 | 9.85 | 4.06 | |
| Short-term investments | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | — | — | — | — | — | — | — | — | 0.00 | 1.56 | 0.25 | 0.00 | |
| Receivables | 1.41 | 1.47 | 1.76 | 1.80 | 1.94 | 2.47 | 2.54 | 3.05 | 3.88 | 4.14 | 4.35 | 5.74 | 7.98 | 8.12 | 8.22 | 8.19 | 8.90 | 9.45 | |
| Inventory | 1.13 | 1.17 | 1.33 | 1.44 | 1.49 | 1.86 | 1.99 | 2.21 | 2.97 | 3.01 | 3.37 | 4.03 | 5.05 | 5.63 | 5.09 | 4.98 | 5.43 | 5.63 | |
| Current assets | 4.53 | 4.14 | 4.82 | 4.83 | 9.88 | 6.54 | 5.74 | 7.02 | 9.42 | 10.63 | 11.89 | 21.96 | 20.11 | 25.23 | 24.59 | 22.14 | 28.71 | 23.37 | |
| Total assets | 21.63 | 21.35 | 26.83 | 27.44 | 31.86 | 42.85 | 40.83 | 45.91 | 56.67 | 56.23 | 58.38 | 69.05 | 95.12 | 97.15 | 98.73 | 97.32 | 110.34 | 113.17 | |
| Current liabilities | 1.64 | 1.71 | 3.11 | 2.09 | 3.13 | 5.35 | 4.15 | 4.87 | 7.05 | 6.15 | 6.20 | 10.30 | 13.44 | 17.01 | 14.01 | 13.33 | 15.19 | 15.07 | |
| Long-term debt | 2.06 | 2.03 | 5.76 | 7.03 | 9.50 | 12.35 | 11.42 | 15.37 | 18.87 | 17.72 | 17.75 | 19.11 | 32.33 | 34.28 | 34.73 | 31.07 | 39.17 | 42.28 | |
| Short-term debt | 0.12 | 0.11 | 1.27 | 0.09 | 0.99 | 2.21 | 1.05 | 1.26 | 2.14 | 1.27 | 0.68 | 2.63 | 2.54 | 5.58 | 3.61 | 2.21 | 3.53 | 3.37 | |
| Shareholders' equity | 15.43 | 15.36 | 15.04 | 15.46 | 16.86 | 20.55 | 21.35 | 21.54 | 25.41 | 27.59 | 29.68 | 34.51 | 40.79 | 43.98 | 46.74 | 49.58 | 53.41 | 52.68 |
USD billions · SEC XBRL
Thermo Fisher Scientific Inc. — questions
- How much cash does Thermo Fisher Scientific Inc. have?
- $4.1B in cash and cash equivalents as of 2026-06-27.
- How much debt does Thermo Fisher Scientific Inc. have?
- $42.3B of long-term debt and $3.4B due within a year as of 2026-06-27.
- What are Thermo Fisher Scientific Inc.'s total assets?
- $113.2B as of 2026-06-27.
- What is Thermo Fisher Scientific Inc.'s shareholders' equity?
- $52.7B as of 2026-06-27.
Every figure on this page comes from Thermo Fisher Scientific Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.